RSS   Newsletter   Contact   Advertise with us

Bundeskartellamt clears merger between Asklepios and Rhön-Klinikum

Christian Fernsby ▼ | June 1, 2020
The Bundeskartellamt has cleared the planned acquisition of up to 100% of the shares in and sole control of Rhön Klinikum AG, Bad Neustadt/Saale, by Asklepios Kliniken GmbH KGaA, Hamburg, in the first phase of merger control.
Asklepios Kliniken GmbH
Klinikum   Asklepios Kliniken GmbH
Asklepios and Rhön are among the largest private hospital operators in Germany, apart from Helios, a subsidiary of Fresenius. Asklepios operates a total of 160 health care centres throughout Germany, including, apart from hospitals, medical care centres and rehabilitation clinics. Rhön operates the clinics Universitätsklinikum Gießen und Marburg, Zentralklinik Bad Berka, Klinikum Frankfurt/Oder and Rhön-Klinikum Campus in Bad Neustadt.

Topics: Asklepios Rhön-Klinikum

Andreas Mundt, President of the Bundeskartellamt: “The catchment areas of the vast majority of the hospital locations of Asklepios and Rhön do not overlap geographically. The two companies are only in competition with each other in the provision of acute in-patient hospital services in the Gießen/Marburg region where Rhön operates Universitätsklinikum Gießen und Marburg as the only privately run university clinic in Germany.

"Asklepios is also active in this region with several hospitals. However, the planned acquisition did not raise any serious competition concerns as the parties’ hospital locations are not close competitors, neither geographically nor functionally.”

Since 2012 the Bundeskartellamt has examined several acquisitions of shares in Rhön by Asklepios. Over the last few years Rhön has sold a large number of hospital locations. In 2017 the Bundeskartellamt already cleared Asklepios’ acquisition of a 25% participation in Rhön.